International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through four segments: Nourish, Scent, Health & Biosciences, and Pharma Solutions. The Nourish segment offers flavor compounds; savory solutions, such as marinades or powder blends of flavors, natural colors, seasonings, functional ingredients, and natural anti-oxidants; and inclusions. It also provides nutrition and specialty ingredients primarily consist of natural health ingredients, natural food protection products, and natural colors and flavor ingredients. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and alginates-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
IPO Year:
Exchange: NYSE
Website: iff.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/12/2024 | $111.00 → $110.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/8/2024 | $107.00 | Neutral → Buy | BofA Securities |
| 11/7/2024 | $109.00 | Hold → Buy | Vertical Research |
| 9/11/2024 | $116.00 → $117.00 | Outperform | Oppenheimer |
| 9/3/2024 | $109.00 → $120.00 | Neutral → Outperform | Mizuho |
| 7/22/2024 | $95.00 → $115.00 | Hold → Buy | Stifel |
| 6/7/2024 | $116.00 | Outperform | Oppenheimer |
| 5/21/2024 | $100.00 | Overweight → Equal-Weight | Morgan Stanley |
| 5/8/2024 | $75.00 → $100.00 | Neutral → Overweight | JP Morgan |
| 4/18/2024 | Underweight → Equal Weight | Barclays |
144 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
11-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
10-Q - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
8-K - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Filer)
New enzymatic solution promises premium textures in fermented dairy and plant-based products, eliminating the need for stabilizers. NEW YORK, Nov. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) today announced the launch of TEXSTAR™, an advanced enzymatic texturizing solution poised to revolutionize the texture of both dairy and plant-based fresh fermented products. This innovative enzyme provides the necessary viscosity in fresh fermented products, without the use of added stabilizers. TEXSTAR™ will enable manufacturers to create products with unique textures that feature familiar, consumer-accepted ingredients. Additionally, the enzyme will allow supply chain fluctuations to be managed more effec
IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $8.7 B $393 M
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we
IFF Science Awards recognize renowned scientists for their remarkable achievements in the field of biosciences. NEW YORK, Oct. 24, 2024 /PRNewswire/ -- This week, IFF (NYSE:IFF) presented two leading university scientists with IFF Science Awards for their work in advancing the future of food, nutrition and health. The IFF Science Awards recognize individuals for their remarkable achievements in the field of science, specifically within food, the microbiome, nutrition, health, biocatalysis and sustainability. This year's recipients are Tom Desmet, Ph.D. of Ghent University in Belgium, and Yolanda Sanz, Ph.D., of the Institute of Agrochemistry and Food Technology (IATA) and the Spanish Researc
Themed "Make joy through science and creativity", concepts will focus on transforming megatrends and innovations into opportunities for the industry DUBAI, UAE, Oct. 23, 2024 /PRNewswire/ -- IFF (NYSE: IFF) is set to unveil a series of groundbreaking food and beverage innovations at Gulfood Manufacturing 2024, from 5-7 Nov., Dubai World Trade Center, Hall 8, booth A8-4, leveraging cutting-edge technologies and deep consumer insights. This year's theme, "Make joy through science and creativity," underscores IFF's focus on transforming megatrends into tangible opportunities for the industry.
New data on OPTIMASH® F200 and OPTIMASH® AX highlights significant oil yield increase and low-carbon market potential NEW YORK, Oct. 21, 2024 /PRNewswire/ -- IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences, and scent, today announced the launch of its OPTIMASH® F200 and OPTIMASH® AX enzyme solutions in combination to maximize corn oil recovery at fuel ethanol plants. New IFF in-plant data shows that this combination can deliver up to 15 percent additional corn oil recovery, helping to meet the growing demand in the biodiesel, renewable diesel, and animal feed industries. Additionally, IFF has developed a proprietary oil mapping calculator to help ethanol producers o
IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from g
Attendees can explore the pivotal role of excipients in drug delivery and gain exclusive insights NEW YORK, Oct. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions will demonstrate the critical role of excipients in drug formulation by showcasing breakthrough research at AAPS 2024 PharmSci 360 in Salt Lake City, Utah, Oct. 20-23, at booth 2705. IFF Pharma Solutions' scientific posters and presentations will unveil key advancements in excipient selection targeting nitrosamine risk mitigation, controlled-release performance, extrusion spheronization processibility and pellet quality, softgel stability, and the formulation of plant-based pharmaceutical gummies. "Our latest research unde
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13G/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
SC 13D/A - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Subject)
IFF (NYSE:IFF) reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $95 M $0.23 $568 M 19.4% $1.04 First Nine Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $8.7 B $393 M
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we
IFF (NYSE:IFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from g
IFF (NYSE:IFF) reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $183 M $0.66 $588 M 20.4% $1.16 First Six Months 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating E
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2024 to shareholders of record as of September 20, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we
IFF (NYSE:IFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on Wednesday, August 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world
IFF (NYSE:IFF) reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Income Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.9 B $115 M $0.23 $578 M 19.9% $1.13 Management Commentary "We have started the year well, with good results across the majority of our business," said IFF CEO Erik Fyrwald. "In the first quarter, we delivered volume growth and productivity gains, which res
IFF (NYSE:IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, scent, health and biosciences, science and creativity meet to create essential solutions for a better world – from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partners with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will d
IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Welcome to IFF At IFF (NYSE:IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world – from glob
IFF (NYSE:IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x. IFF's Pharma Solutions business is a well-established developer and manufacturer of pharmaceutical excipients and includes its Global Specialty Solutions business supporting industrial and methyl cellulosic food applications. The Pharma Solutions business being sold to Roquette is primarily made up of businesses within IFF's existing Pharma Solutions division, with some adjustments to the perime
Stifel analyst Mark S. Astrachan upgraded International Flavors & Fragrances Inc. (NYSE:IFF) stock to Buy from Hold with an increased price target of $115 from $95. The analyst sees 2024 guidance as conservative and is increasing the sales and adjusted EBITDA forecasts for 2024-2025 by 1.5% and 4.4% above the company’s top-end targets. IFF’s volumes rebounded strongly in the first-quarter 2024, rising mid-single-digits after five quarters of decline, writes the analyst. Also Read: IFF’s Focus On Health And Environment Set To Drive Stock Momentum, Says Analyst Astrachan expects mid-single-digit volume growth throughout 2024, driven by improved comparisons and a return to growth am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs cut the price target for Lennar Corporation (NYSE:LEN) from $180 to $174. Goldman Sachs analyst Susan Maklari downgraded the stock from Buy to Neutral. Lennar shares gained 0.5% to close at $170.94 on Friday. See how other analysts view this stock. Piper Sandler increased the price target for NVIDIA Corporation (NASDAQ:NVDA) from $120 to $140. Piper Sandler analyst Harsh Kumar maintained an Overweight rating. NVIDIA shares fell 2.6% to close at $117.93 on Friday. See how other analyst
Intl Flavors & Fragrances (NYSE:IFF) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 4 7 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 2 0 0 2M Ago 0 1 0 0 0 3M Ago 1 3 5 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $104.5, with a high estimate of $116.00 and a low estimate of $93.00. Observing a 11.35% increase, the current av
Stifel analyst Mark Astrachan upgrades Intl Flavors & Fragrances (NYSE:IFF) from Hold to Buy and raises the price target from $95 to $115.
Citigroup analyst Patrick Cunningham maintains Intl Flavors & Fragrances (NYSE:IFF) with a Buy and raises the price target from $108 to $116.
UBS analyst Joshua Spector maintains Intl Flavors & Fragrances (NYSE:IFF) with a Neutral and raises the price target from $95 to $100.
In the latest quarter, 13 analysts provided ratings for Intl Flavors & Fragrances (NYSE:IFF), showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 4 6 1 0 Last 30D 0 0 1 0 0 1M Ago 0 1 0 0 0 2M Ago 1 3 5 0 0 3M Ago 1 0 0 1 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $100.54, a high estimate of $116.00, and a low estimate of $75.00. This upward trend is apparent, with the current av
Morgan Stanley analyst Lisa De Neve maintains Intl Flavors & Fragrances (NYSE:IFF) with a Equal-Weight and raises the price target from $100 to $103.
IFF today announced EU-wide regulatory approval for two of its groundbreaking feed solutions for poultry. Axtra® XAP – a multi-enzyme blend and Syncra® AVI – an enzyme-probiotic complex from Danisco Animal Nutrition & Health, IFF's Health & Biosciences business unit, are formulated to meet the challenges of modern poultry production and deliver measurable performance improvements. "Obtaining full EU authorization empowers us to unleash the remarkable potential of these two exceptional in-feed products to poultry producers across the region," said Jose Luis Ecija Roux, marketing director EMEA, Danisco Animal Nutrition & Health. "Axtra® XAP and Syncra® AVI have demonstrated their pivotal r
Oppenheimer & Co. Inc. analyst Kristen Owen initiated coverage on International Flavors & Fragrances Inc. (NYSE:IFF) with an Outperform rating and a price target of $116. The analyst says that IFF aligns with their focus on meaningful molecules, reflecting consumers’ shifting trend toward health and environmental consciousness. There’s potential for a significant shift in the company’s shareholder base as its portfolio rationalization focuses on key categories, driving improved return on invested capital (ROIC) and strengthening the balance sheet, writes that analyst. The analyst says that as IFF progresses into the third phase of its transformation, the stock has seen initial posit
Morgan Stanley upgraded Intl Flavors from Equal-Weight to Overweight and set a new price target of $110.00 from $111.00 previously
BofA Securities upgraded Intl Flavors from Neutral to Buy and set a new price target of $107.00
Vertical Research upgraded Intl Flavors from Hold to Buy and set a new price target of $109.00
Oppenheimer reiterated coverage of Intl Flavors with a rating of Outperform and set a new price target of $117.00 from $116.00 previously
Mizuho upgraded Intl Flavors from Neutral to Outperform and set a new price target of $120.00 from $109.00 previously
Stifel upgraded Intl Flavors from Hold to Buy and set a new price target of $115.00 from $95.00 previously
Oppenheimer initiated coverage of Intl Flavors with a rating of Outperform and set a new price target of $116.00
Morgan Stanley downgraded Intl Flavors from Overweight to Equal-Weight and set a new price target of $100.00
JP Morgan upgraded Intl Flavors from Neutral to Overweight and set a new price target of $100.00 from $75.00 previously
Barclays upgraded Intl Flavors from Underweight to Equal Weight
Alexandra Carlin and Alex Lee join the Paris-based fine fragrance team, bringing fresh artistic perspectives PARIS, Nov. 4, 2024 /PRNewswire/ -- IFF (NYSE:IFF) proudly welcomes Alexandra Carlin as Senior Fine Fragrance Perfumer and Alex Lee as Fine Fragrance Perfumer to its Paris-based team. These strategic additions aim to enhance the Company's creative prowess in the world of perfumery. "We're excited for the talent and creative energy that Alexandra and Alex will bring to IFF Scent," said Sabrya Meflah, president, Fine Fragrance, IFF. "Alexandra's ability to translate deep
NEW YORK, Sept. 26, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches and technologies for the pharmaceutical and biotech industries. Celebrating this pivotal milestone, IFF will spotlight its latest solutions for nitrosamine mitigation at CPHI 2024, Milan, Oct. 8-10, booth 6B10. The range includes a new portfolio of low nitrite excipients and ultrapure alginate biopolymers for next-generation therapeutic development. "We are unveiling groundbreaking technologies that re
IFF (NYSE:IFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF's previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent. "We are pleased to welcome Maggie to the IFF Board," said Roger Ferguson, lead director of IFF. "Her legal expertise, consumer insights, and her experience in emerging markets will be invaluable to IFF as we continue to execute on our growth and transformation plan to drive in
International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.7 B $(2.6) B $(10.21) $461 M 17.1% $0.72 Full Year 2023 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes EPS
NEW YORK, Feb. 15, 2024 /PRNewswire/ -- IFF today announced the promotion of three perfumers to vice president perfumers: Patricia "Patty" Hidalgo, Joa Kim and Birgit Sijbrands. Patricia "Patty" Hidalgo — a beacon of creativity and innovation in the fragrance industry with a storied career spanning three decades — began her journey at IFF by joining through the Fragrance Resources acquisition in 2017. A scholar in biology and chemistry, her technical skills propelled her from a laboratory technician to a towering strength in perfumery creation, where she has since been craftin
IFF (NYSE:IFF) today announced the appointment of J. Erik Fyrwald to succeed Frank Clyburn as Chief Executive Officer and member of the IFF Board of Directors, effective Feb. 6, 2024. Clyburn will work closely with Fyrwald to ensure a seamless transition, remaining with IFF until March 31, 2024, and further serving in an advisory capacity through December 2024. Fyrwald brings to IFF more than four decades of executive and operational experience driving innovation and profitable, sustainable growth at leading corporations in the nutrition, agriculture and chemicals industries. He most recently served as Chief Executive Officer of Syngenta, where he spearheaded the strategy that ultimately
International Flavors & Fragrances Inc. (NYSE:IFF) reported financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $2.8 B $(5) M $0.01 $441 M 15.5% $0.97 Full Year 2022 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes EPS Operating EBITDA Operating EBITDA Margin EPS ex Amortization $12.4 B $(1.
IFF (NYSE:IFF) today announced the appointment of Gary Hu to the Company's Board of Directors, effective Feb. 1, 2023. Hu, a portfolio manager at Icahn Capital, will be appointed to the Board's Audit and Transaction Committees. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP and its affiliates. "On behalf of the IFF Board of Directors, I would like to welcome Gary to the Board," said Dale Morrison, chairman of IFF's Board of Directors. "We expect that Gary's board experience – coupled with his financial and investment expertise – will prove a solid addition to our Board. We look forward to working alongside him as we continue to execu
IFF (NYSE:IFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company's Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesses. "We are thrilled to welcome Dawn to the IFF Board as we continue to evolve our Board consistent with the plans announced in our December Investor Day, and prioritize the addition of senior executives with the most relevant s
NEW YORK, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. (NASDAQ:EXLS), a leading global data analytics and digital operations and solutions company, today announced that Andreas Fibig, a seasoned global executive with a strong record of innovation across industries and geographies, has been appointed to EXL's Board of Directors as an independent director effective Jan. 10, 2023. Fibig will be a member of the Board's Audit and Nominating and Governance Committees. "Andreas is a distinguished global business leader with more than 25 years of international health care, pharmaceutical, and consumer industry experience," said Vikram S. Pandit, Chairman of the Board of EXL. "We lo
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
3 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)
4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)